COVID Vaccine 2025-2026 Formula Will Be JN.1 Lineage, With Preference for LP.8.1 Strain: VRBPAC Members Question Impact of New Framework on Availability; FDA Has No Answers

You must be a logged-in member of this site to view this article.

To request more information about a company license to the Prevision Policy continuous information service or to get further details about the services we offer, please click here.

Alternatively, if your organization already has a license and you do not yet have an account, please click here to request access.